Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

ETR/GIS stock hub

ETR/GIS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/GISis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

138.5B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/GIS

In the news

Latest news · ETR/GIS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/E17.3

P25 16.4P50 20.9P75 30.4

ROE43.4

P25 -6.7P50 8.5P75 17.2

ROIC27.7

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/GIS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	17,000
Employees Change	-600%
Employees Change Percent	-3.41
Enterprise value	EUR 148.1B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US3755581036
Last refreshed	2026-05-10
Market cap	EUR 138.5B
Price	EUR 111
Price currency	EUR
Rev Per Employee	1,517,060.75x
Sector	Healthcare
Sic	2836
Symbol	etr/GIS
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.77%
EV Earnings	18.53x
EV/EBIT	14.55x
EV/EBITDA	11.7x
EV/FCF	16.69x
EV/Sales	5.86x
FCF yield	6.4%
P/B ratio	6.82x
P/E ratio	17.33x
P/S ratio	5.37x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	34.4%
Gross margin	79.37%
Gross Profit	EUR 20.5B
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	EUR 8B
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	EUR 470,179
Profitable Years	19
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.89%
Cagr15y	17.74%
Cagr1y	30.63%
Cagr3y	19.52%
Cagr5y	19.38%
Div CAGR10	5.94%
Div CAGR3	-0.88%
Div CAGR5	3.31%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth Quarters	6
EPS Growth Years	1
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 48.8B
Cash	EUR 8.5B
Current Assets	EUR 15.8B
Current Liabilities	EUR 8B
Debt	EUR 19.2B
Debt EBITDA	EUR 1.49
Debt Equity	EUR 0.95
Debt FCF	EUR 2.17
Equity	EUR 20.3B
Interest Coverage	11.94
Liabilities	EUR 28.5B
Long Term Assets	EUR 33B
Long Term Liabilities	EUR 20.5B
Net Cash	EUR -9.9B
Net Cash By Market Cap	EUR -7.12
Net Debt EBITDA	EUR 0.77
Net Debt Equity	EUR 0.49
Net Debt FCF	EUR 1.11
Tangible Book Value	EUR -1B
Tangible Book Value Per Share	EUR -0.82
WACC	5.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	EUR 573.3M
Quick ratio	1.54
Working Capital	EUR 7.9B
Working Capital Turnover	EUR 3.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	-4.64%
Dividend Growth Years	0%
Dividend per share	EUR 2.74
Dividend Years	12
Dividend Yield	2.47%
Ex Div Date	2026-03-13
Last Dividend	EUR 0.71
Payout Frequency	Quarterly
Payout Ratio	43.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	113.75%
1Y total return	30.6%
200-day SMA	109
3Y total return	70.77%
50-day SMA	119.5
50-day SMA vs 200-day SMA	50over200
5Y total return	142.45%
All Time High	132
All Time High Change	-15.92%
All Time High Date	2026-02-18
All Time Low	12
All Time Low Change	824.83%
All Time Low Date	2007-01-24
ATR	2.37
Beta	0.33
Ch YTD	4.42
High	113.8
High52	132
High52 Date	2026-02-18
High52ch	-15.92%
Low	110.1
Low52	82.04
Low52 Date	2025-05-12
Low52ch	35.28%
Ma50ch	-7.1%
Price vs 200-day SMA	1.8%
RSI	37.4
RSI Monthly	60.2
RSI Weekly	46.78
Sharpe ratio	1.05x
Sortino ratio	1.96
Total Return	2.81%
Tr YTD	5.01
Tr15y	1,058.84%
Tr1m	-7.07%
Tr1w	-1.8%
Tr3m	-12.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 10.4B
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,252,307%
Net Borrowing	-2,367,509,904
Shares Insiders	0.1%
Shares Institutions	88.48%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 8.1B
Average Volume	897.65x
Bv Per Share	16.42
CAPEX	EUR -499.6M
Ch10y	50.22
Ch15y	700.8
Ch1m	-7.07
Ch1w	-1.8
Ch1y	27.24
Ch3m	-13.26
Ch3y	54.23
Ch5y	101.3
Ch6m	6.45
Change	-3.23%
Change From Open	-2.25
Close	114.7
Days Gap	-0.99
Depreciation Amortization	2,334,439,386
Dollar Volume	382,881
Earnings Date	2026-05-07
EBIT	EUR 10.4B
EBITDA	EUR 12.8B
EPS	EUR 6.38
F Score	8
FCF	EUR 8.9B
FCF EV Yield	5.99x
Financing CF	-7,422,353,400
Fiscal Year End	December
Founded	1,987
Goodwill	7,049,956,068
Graham Number	48.43088
Graham Upside	-56.36
Income Tax	EUR 1.3B
Investing CF	-2,261,918,400
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2013-01-28
Last Split Type	Forward
Lynch Fair Value	EUR 160
Lynch Upside	44.25
Ma150	112.7
Ma150ch	-1.51%
Ma20	114.2
Ma20ch	-2.85%
Net CF	-257,588,100
Next Earnings Date	2026-08-06
Open	113.5
P FCF Ratio	15.61
P OCF Ratio	14.78
Payment Date	2026-03-30
Position In Range	23.5
Ppne	4,780,809,756
Price Date	2026-05-08
Price EBITDA	EUR 10.84
Relative Volume	4.58x
Revenue	25,790,032,800x
SBC By Revenue	3.04x
Share Based Comp	783,171,900
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	7.74%
Volume	3,450
Z Score	4.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/GIS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$2.74 annual per share

Payout ratio

+43.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.3%

0 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-03-13

Performance

ETR/GIS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/GIS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/GIS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

+1.8%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/GIS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/GIS stock rating?

etr/GIS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/GIS analysis?

The full report lives at /stocks/etr/GIS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/GIS?

The latest report frames etr/GIS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/GIS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.